Envestnet Portfolio Solutions, Inc.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1998033 BERWYN, PA

Position in HALO

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$892,982

+$150,965 QoQ

Shares Held

11,409

-0.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#318

of 664 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Envestnet Portfolio Solutions, Inc. holds $15,944,229 across 18 Biotechnology names. HALO ranks #7 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,064	$4,005,630
2	JAZZ	Jazz Pharmaceuticals plc	8,030	$1,934,989
3	ALNY	Alnylam Pharmaceuticals, Inc.	4,635	$1,395,274
4	TGTX	Tg Therapeutics, Inc.	21,192	$1,164,288
5	PTCT	Ptc Therapeutics, Inc.	13,730	$1,119,956
6	CORT	Corcept Therapeutics Inc	10,617	$923,148
7	HALO	Halozyme Therapeutics, Inc. This page	11,409	$892,982
8			21,996	$691,334

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$892,982	11,409	-0.6%	Shares	Sole	2026-07-20
2026-03-31	$742,017	11,481	-18.2%	Shares	Sole	2026-04-29
2025-12-31	$944,084	14,028	+3.6%	Shares	Sole	2026-02-06
2025-09-30	$993,243	13,543	-18.0%	Shares	Sole	2025-10-30
2025-06-30	$858,642	16,506	+46.2%	Shares	Sole	2025-07-25
2025-03-31	$720,542	11,292	-35.2%	Shares	Sole	2025-04-21
2024-12-31	$833,567	17,435	-2.5%	Shares	Sole	2025-02-10
2024-09-30	$1,023,508	17,881	+55.9%	Shares	Sole	2024-10-31
2024-06-30	$600,412	11,467	+21.3%	Shares	Sole	2024-07-16
2024-03-31	$384,466	9,451	-14.7%	Shares	Sole	2024-05-06
2023-12-31	$409,627	11,083	-11.2%	Shares	Sole	2024-02-07
2023-09-30	$476,621	12,477	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.